Patrick B Deegan

Author PubWeight™ 8.43^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease.	Hepatology	2013	1.78
2	Clinical Features of Lysosomal Acid Lipase Deficiency.	J Pediatr Gastroenterol Nutr	2015	0.92
3	Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years.	Br J Haematol	2012	0.88
4	Response of women with Fabry disease to enzyme replacement therapy: comparison with men, using data from FOS--the Fabry Outcome Survey.	Mol Genet Metab	2011	0.88
5	Potential biomarkers of osteonecrosis in Gaucher disease.	Blood Cells Mol Dis	2010	0.84
6	Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes.	Haematologica	2012	0.83
7	Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency.	Mol Genet Metab	2012	0.83
8	Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease.	J Med Genet	2012	0.77
9	Biomarkers for osteonecrosis in Gaucher disease.	Expert Opin Med Diagn	2011	0.76